Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src
Zhenxi Li,Xinghai Yang,Ruifeng Fu,Zhipeng Wu,Shengzhao Xu,Jian Jiao,Ming Qian,Long Zhang,Chunbiao Wu,Tianying Xie,Jiqiang Yao,Zhixiang Wu,Wenjun Li,Guoli Ma,Yu You,Yihua Chen,Han-kun Zhang,Yiyun Cheng,Xiaolong Tang,Pengfei Wu,Gewei Lian,Haifeng Wei,Jian Zhao,Jianrong Xu,Lianzhong Ai,Stefan Siwko,Yue Wang,Jin Ding,Gaojie Song,Jian Luo,Mingyao Liu,Jianru Xiao
DOI: https://doi.org/10.1038/s41467-024-44852-9
IF: 16.6
2024-02-12
Nature Communications
Abstract:Abstract Osteoclasts are over-activated as we age, which results in bone loss. Src deficiency in mice leads to severe osteopetrosis due to a functional defect in osteoclasts, indicating that Src function is essential in osteoclasts. G-protein-coupled receptors (GPCRs) are the targets for ∼35% of approved drugs but it is still unclear how GPCRs regulate Src kinase activity. Here, we reveal that GPR54 activation by its natural ligand Kisspeptin-10 (Kp-10) causes Dusp18 to dephosphorylate Src at Tyr 416. Mechanistically, Gpr54 recruits both active Src and the Dusp18 phosphatase at its proline/arginine-rich motif in its C terminus. We show that Kp-10 binding to Gpr54 leads to the up-regulation of Dusp18. Kiss1 , Gpr54 and Dusp18 knockout mice all exhibit osteoclast hyperactivation and bone loss, and Kp-10 abrogated bone loss by suppressing osteoclast activity in vivo. Therefore, Kp-10/Gpr54 is a promising therapeutic target to abrogate bone resorption by Dusp18-mediated Src dephosphorylation.
multidisciplinary sciences